Acute Cycling on Executive Control (ACE)

June 19, 2018 updated by: Dr. Harry Prapavessis, Western University, Canada

The Effects of Acute Cycling on Executive Control

This study will examine whether 10-minute bouts of cycling at various intensities will impact executive functioning (i.e., cognitive ability) as assessed by the antisaccade (AS) task through a total of five visits. An antisaccade is a rapid eye movement away from a visual target. The ability to suppress making an eye movement towards a visual target gauges inhibitory control (i.e., a domain of executive functioning). In the initial visit, participants' exercise capacity will be assessed through a maximal effort cycling test. Intensities for the cycling bouts (i.e., high, moderate, low) in subsequent sessions will be based upon this maximal effort cycling test. In visits 2 through 5, participants will complete an AS task, followed by a 10-minute bout of cycling, and then complete the AS task again. The order of cycling intensities will be randomized between participants. Differences in the AS task (i.e., reaction time and accuracy) will be compared between and within cycling conditions.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Harry Prapavessis, Ph.D
  • Phone Number: 80173 5196612111
  • Email: hprapave@uwo.ca

Study Contact Backup

  • Name: Kirsten B Dillon, B.Sc
  • Phone Number: 6043566359
  • Email: kdillon9@uwo.ca

Study Locations

    • Ontario
      • London, Ontario, Canada, N6A3K7
        • Western University
        • Contact:
          • Harry Prapavessis, Ph.D

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 64 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Able to read, write and understand English
  • Full time student enrolled at Western University
  • Able to perform a ten-minute exercise task at a light intensity without health implications
  • Have email or phone number for contacting purposes

Exclusion Criteria:

  • Do not have a medical condition that prevents you from exercise (e.g. heart attack in the past year, heart disease, irregular heartbeat, etc.)
  • Do not have history of eye injury or neurological impairment
  • Do not have an orthopaedic limitation
  • Are not pregnant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Sitting
The participant will be asked to sit for 10 min (not increasing their heart rate) then do the anti-saccade task
10 min bouts
EXPERIMENTAL: Low-Intensity Cycling
Participant will be asked to cycle for 10 min (<40% VO2R) and then perform the anti-saccade task
10min bout
EXPERIMENTAL: Moderate-Intensity Cycling
The participant will be asked to do 10 min of cycling (40-59% VO2R) followed but the anti-saccade task
10 min bout
EXPERIMENTAL: High-Intensity Cycling
The participant will be asked to do 10 min of cycling (60%-84% VO2R) followed but the anti-saccade task
10 min bout

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reaction Time
Time Frame: 30 minutes
Time in milliseconds to target
30 minutes
Accuracy
Time Frame: 30 minutes
Directional errors
30 minutes

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart Rate
Time Frame: 10 minutes
Heart rate measured in beats per minute with a Polar Heart Rate Monitor as a manipulation check
10 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

July 1, 2018

Primary Completion (ANTICIPATED)

December 31, 2018

Study Completion (ANTICIPATED)

July 31, 2019

Study Registration Dates

First Submitted

April 9, 2018

First Submitted That Met QC Criteria

April 9, 2018

First Posted (ACTUAL)

April 17, 2018

Study Record Updates

Last Update Posted (ACTUAL)

June 21, 2018

Last Update Submitted That Met QC Criteria

June 19, 2018

Last Verified

June 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • PA and Executive Functioning

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Activity

Clinical Trials on Sitting

3
Subscribe